Immunotherapy of melanoma with the immune costimulatory monoclonal antibodies targeting CD137
Shi-Yan Li, Yizhen Liu Cancer Research Institute, Scott and White Healthcare, Temple, TX, USA Abstract: Knowledge of how the immune system recognizes and attempts to control cancer growth and development has improved dramatically. The advent of immunotherapies for cancer has resulted in robust clini...
Guardado en:
Autores principales: | Li SY, Liu Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1cbbf2420ab54533883a9b795cdf6c50 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer
por: Eskander RN, et al.
Publicado: (2013) -
Use of ipilimumab in the treatment of melanoma
por: Acharya UH, et al.
Publicado: (2013) -
Arginine deprivation therapy for malignant melanoma
por: Yoon JK, et al.
Publicado: (2012) -
Generation and characterization of tabalumab, a human monoclonal antibody that neutralizes both soluble and membrane-bound B-cell activating factor
por: Manetta J, et al.
Publicado: (2014) -
REGN1908‐1909 monoclonal antibodies block Fel d 1 in cat allergic subjects: Translational pharmacokinetics and pharmacodynamics
por: Mohamed A. Kamal, et al.
Publicado: (2021)